Daily Nattokinase reduced carotid artery plaque by 36% in 1 year
In a 12-month trial of 1,062 men & women (average age 68), daily Nattokinase at 10,800 FU/day was shown to significantly reduce carotid artery plaque, alongside improvements in total cholesterol (95.4% of patients), LDL (84.3%), HDL (89.1%) and triglycerides (85.2%).
View study (DOI: 10.3389/fcvm.2022.964977) →

